EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial intelligence-based point-of-care lung ultrasound for screening COVID-19 pneumoniae: Comparison with CT scans

Yumi Kuroda, Tomohiro Kaneko, Hitomi Yoshikawa, Saori Uchiyama, Yuichi Nagata, Yasushi Matsushita, Makoto Hiki, Tohru Minamino iD, Kazuhisa Takahashi, Hiroyuki Daida, Nobuyuki Kagiyama iD

PLOS ONE · 16.03.2023 · 18 (3) · e0281127

DOI: 10.1371/journal.pone.0281127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 16.03.2023. Verfasst von Yumi Kuroda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Pneumonia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although lung ultrasound has been reported to be a portable, cost-effective, and accurate method to detect pneumonia, it has not been widely used because of the difficulty in its interpretation. Here, we aimed to investigate the effectiveness of a novel artificial intelligence-based automated pneumonia detection method using point-of-care lung ultrasound (AI-POCUS) for the coronavirus disease 2019 (COVID-19).

Methods

We enrolled consecutive patients admitted with COVID-19 who underwent computed tomography (CT) in August and September 2021. A 12-zone AI-POCUS was performed by a novice observer using a pocket-size device within 24 h of the CT scan. Fifteen control subjects were also scanned. Additionally, the accuracy of the simplified 8-zone scan excluding the dorsal chest, was assessed. More than three B-lines detected in one lung zone were considered zone-level positive, and the presence of positive AI-POCUS in any lung zone was considered patient-level positive. The sample size calculation was not performed given the retrospective all-comer nature of the study.

Results

A total of 577 lung zones from 56 subjects (59.4 ± 14.8 years, 23% female) were evaluated using AI-POCUS. The mean number of days from disease onset was 9, and 14% of patients were under mechanical ventilation. The CT-validated pneumonia was seen in 71.4% of patients at total 577 lung zones (53.3%). The 12-zone AI-POCUS for detecting CT-validated pneumonia in the patient-level showed the accuracy of 94.5% (85.1%– 98.1%), sensitivity of 92.3% (79.7%– 97.3%), specificity of 100% (80.6%– 100%), positive predictive value of 95.0% (89.6% - 97.7%), and Kappa of 0.33 (0.27–0.40). When simplified with 8-zone scan, the accuracy, sensitivity, and sensitivity were 83.9% (72.2%– 91.3%), 77.5% (62.5%– 87.7%), and 100% (80.6%– 100%), respectively. The zone-level accuracy, sensitivity, and specificity of AI-POCUS were 65.3% (61.4%– 69.1%), 37.2% (32.0%– 42.7%), and 97.8% (95.2%– 99.0%), respectively.

Interpretation

AI-POCUS using the novel pocket-size ultrasound system showed excellent agreement with CT-validated COVID-19 pneumonia, even when used by a novice observer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PneumoniaHumansFemaleMaleArtificial IntelligencePoint-of-Care SystemsRetrospective StudiesLungTomography, X-Ray Computed

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Emergency Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Internal Medicine and Rheumatology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Digital Health and Telemedicine R&D, Juntendo University, Bunkyo-ku, Tokyo, Japan.

ORCID-Profile: Tohru Minamino, Nobuyuki Kagiyama

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kuroda, Y., Kaneko, T., Yoshikawa, H., Uchiyama, S., Nagata, Y., Matsushita, Y., Hiki, M., Minamino, T., Takahashi, K., Daida, H., & Kagiyama, N. (2023). Artificial intelligence-based point-of-care lung ultrasound for screening COVID-19 pneumoniae: Comparison with CT scans. PLOS ONE, 18(3), e0281127. https://doi.org/10.1371/journal.pone.0281127

Vancouver

Kuroda Y, Kaneko T, Yoshikawa H, Uchiyama S, Nagata Y, Matsushita Y, et al. Artificial intelligence-based point-of-care lung ultrasound for screening COVID-19 pneumoniae: Comparison with CT scans. PLOS ONE. 2023;18(3):e0281127. doi:10.1371/journal.pone.0281127

BibTeX
@article{Kuroda2023,
  author = {Kuroda, Yumi and Kaneko, Tomohiro and Yoshikawa, Hitomi and Uchiyama, Saori and Nagata, Yuichi and Matsushita, Yasushi and Hiki, Makoto and Minamino, Tohru and Takahashi, Kazuhisa and Daida, Hiroyuki and Kagiyama, Nobuyuki},
  title = {Artificial intelligence-based point-of-care lung ultrasound for screening COVID-19 pneumoniae: Comparison with CT scans},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0281127},
  doi = {10.1371/journal.pone.0281127}
}
Kostenlos starten →